---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-063785"
form_type: "8-K"
ticker: "LENZ"
cik: "0001815776"
company_name: "LENZ Therapeutics, Inc."
filed_at: "2024-03-08T23:59:59+00:00"
generated_at: "2026-06-05T00:41:46.580337+00:00"
event_type: "dividend"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Graphite Bio declares special $1.03/share dividend tied to Lenz merger

## Summary
- Special dividend estimated at $1.03 per share, capped at $60M.
- Record date March 18, 2024; payment date March 21, 2024.
- Dividend contingent on closing of merger with Lenz Therapeutics.
- Graphite stockholders vote on merger at special meeting March 14, 2024.

## SEC filing metadata
- accession: 0001193125-24-063785
- form_type: 8-K
- ticker: LENZ
- cik: 0001815776
- company_name: LENZ Therapeutics, Inc.
- filed_at: 2024-03-08T23:59:59+00:00
- event_type: dividend
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815776/000119312524063785/0001193125-24-063785-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815776/000119312524063785/d784350d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-063785
- JSON: https://secwatch.observer/filing/0001193125-24-063785.json
- Plain text: https://secwatch.observer/filing/0001193125-24-063785.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.